CD8A and neoplasm: Histology of lesions from C57Bl/6 mice injected subcutaneously with B16shR-SOCS1 cells showed enhanced cellular infiltrate, T-CD8 cells and NK1.1 cells (Fig. 6A) and reduction of tumor invasiveness.